BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 30405833)

  • 1. miRNA-21 and miRNA-223 expression signature as a predictor for lymph node metastasis, distant metastasis and survival in kidney renal clear cell carcinoma.
    Yu L; Xiang L; Feng J; Li B; Zhou Z; Li J; Lin Y; Lv Y; Zou D; Lei Z; Zhang J
    J Cancer; 2018; 9(20):3651-3659. PubMed ID: 30405833
    [No Abstract]   [Full Text] [Related]  

  • 2. A three-microRNA signature as a diagnostic and prognostic marker in clear cell renal cancer: An In Silico analysis.
    Liang B; Zhao J; Wang X
    PLoS One; 2017; 12(6):e0180660. PubMed ID: 28662155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel M7G-Related MicroRNAs Risk Signature Predicts the Prognosis and Tumor Microenvironment of Kidney Renal Clear Cell Carcinoma.
    Hong P; Du H; Tong M; Cao Q; Hu D; Ma J; Jin Y; Li Z; Huang W; Tong G
    Front Genet; 2022; 13():922358. PubMed ID: 35812727
    [No Abstract]   [Full Text] [Related]  

  • 4. A microRNA-clinical prognosis model to predict the overall survival for kidney renal clear cell carcinoma.
    Zhan Y; Zhang R; Li C; Xu X; Zhu K; Yang Z; Zheng J; Guo Y
    Cancer Med; 2021 Sep; 10(17):6128-6139. PubMed ID: 34288551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Four-miRNA signature as a prognostic tool for lung adenocarcinoma.
    Lin Y; Lv Y; Liang R; Yuan C; Zhang J; He D; Zheng X; Zhang J
    Onco Targets Ther; 2018; 11():29-36. PubMed ID: 29317831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Five-microRNA Signature as Prognostic Biomarker in Colorectal Cancer by Bioinformatics Analysis.
    Yang G; Zhang Y; Yang J
    Front Oncol; 2019; 9():1207. PubMed ID: 31799184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.
    Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J
    J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low expression of SLC34A1 is associated with poor prognosis in clear cell renal cell carcinoma.
    Qiu J; Wang Z; Xu Y; Zhao L; Zhang P; Gao H; Wang Q; Xia Q
    BMC Urol; 2023 Mar; 23(1):45. PubMed ID: 36978048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The miR-183/182/96 cluster functions as a potential carcinogenic factor and prognostic factor in kidney renal clear cell carcinoma.
    Yuan J; Dong R; Liu F; Zhan L; Liu Y; Wei J; Wang N
    Exp Ther Med; 2019 Apr; 17(4):2457-2464. PubMed ID: 30906433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A three miRNAs signature predicts survival in cervical cancer using bioinformatics analysis.
    Liang B; Li Y; Wang T
    Sci Rep; 2017 Jul; 7(1):5624. PubMed ID: 28717180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Validation of Nine-RNA Binding Protein Signature Predicting Overall Survival for Kidney Renal Clear Cell Carcinoma.
    Zhong W; Huang C; Lin J; Zhu M; Zhong H; Chiang MH; Chiang HS; Hui MS; Lin Y; Huang J
    Front Genet; 2020; 11():568192. PubMed ID: 33133154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and validation of a four-miRNA (miRNA-21-5p, miRNA-9-5p, miR-149-5p, and miRNA-30b-5p) prognosis signature in clear cell renal cell carcinoma.
    Xie M; Lv Y; Liu Z; Zhang J; Liang C; Liao X; Liang R; Lin Y; Li Y
    Cancer Manag Res; 2018; 10():5759-5766. PubMed ID: 30532596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A polyamine metabolism risk signature for predicting the prognosis and immune therapeutic response of kidney cancer.
    Li B; Kong Z; Liu Y; Xu B; Liu X; Li S; Zhang Z
    Transl Cancer Res; 2023 Oct; 12(10):2477-2492. PubMed ID: 37969387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel three‑miRNA signature predicts survival in cholangiocarcinoma based on RNA‑Seq data.
    Cao J; Sun L; Li J; Zhou C; Cheng L; Chen K; Yan B; Qian W; Ma Q; Duan W
    Oncol Rep; 2018 Sep; 40(3):1422-1434. PubMed ID: 29956786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A four-miRNA signature as a novel biomarker for predicting survival in endometrial cancer.
    Wu YS; Lin H; Chen D; Yi Z; Zeng B; Jiang Y; Ren G
    Gene; 2019 May; 697():86-93. PubMed ID: 30779946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of a new prognostic risk model of MAPK pathway-related molecules in kidney renal clear cell carcinoma based on genomes and transcriptomes analysis.
    Zhang P; Li J; Wang Z; Zhao L; Qiu J; Xu Y; Wu G; Xia Q
    Front Oncol; 2023; 13():1077309. PubMed ID: 36969076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA related prognosis biomarkers from high throughput sequencing data of kidney renal clear cell carcinoma.
    Huang M; Zhang T; Yao ZY; Xing C; Wu Q; Liu YW; Xing XL
    BMC Med Genomics; 2021 Mar; 14(1):72. PubMed ID: 33750388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long Non-Coding RNA Profile Study Identifies an Immune-Related lncRNA Prognostic Signature for Kidney Renal Clear Cell Carcinoma.
    Sun Z; Jing C; Xiao C; Li T
    Front Oncol; 2020; 10():1430. PubMed ID: 32974157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Prognostic and Metastatic Alternative Splicing Signatures in Kidney Renal Clear Cell Carcinoma.
    Meng T; Huang R; Zeng Z; Huang Z; Yin H; Jiao C; Yan P; Hu P; Zhu X; Li Z; Song D; Zhang J; Cheng L
    Front Bioeng Biotechnol; 2019; 7():270. PubMed ID: 31681747
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of a 4-miRNA signature as a potential prognostic biomarker for pancreatic adenocarcinoma.
    Wang ZX; Deng TX; Ma Z
    J Cell Biochem; 2019 Oct; 120(10):16416-16426. PubMed ID: 31297864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.